RAD December 2023 Abstracts and Posters
All accepted abstracts will be published in The British Journal of Dermatology.565 - Safety and Pharmacokinetic Profiles of a Humanized Monoclonal Antibody TQH2722 Targeting Interleukin 4 receptor alpha (IL-4Rα) in Healthy Adult Subjects
Pingping Lin, Feifei Sun, Yi Xu, Rongxin Ban, Xin Jiang, Yao Fu, Xiaomeng Gao, Yu Cao
566 - Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial
Margitta Worm, Eric L. Simpson, Golara Honari, Weily Soong, Andreas Pinter, Koji Masuda, Liyang Shao, Ariane Dubost-Brama, Ashish Bansal, Andrew Korotzer, Ana B. Rossi
568 - Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from TARGET-DERM registry
Lawrence F. Eichenfield MD, Ayman Grada MD, Keith D. Knapp PhD, Breda Munoz PhD, Julie M. Crawford MD, Jonathan I Silverberg on behalf of the TARGET-DERM AD Investigators
569 - Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry
Brenda Simpson MD, Ayman Grada MD, Keith D. Knapp PhD, Breda Munoz PhD, Julie M. Crawford MD, Jonathan I. Silverberg MD PhD MPH on behalf of the TARGET-DERM AD Investigators